Neurofibromatosis type 1 is a complex autosomal dominant disorder caused by germline
mutations in the NF1 tumour suppressor gene. Nearly all individuals with neurofibromatosis …

Recent worldwide epidemiological surveys of autism conducted in 37 countries are
reviewed; the median prevalence of autism is. 97% in 26 high-income countries …

Neuroibromatosis type 1 (NF1) is a multisystem disorder that primarily involves the skin and
peripheral nervous system. Its population prevalence is approximately 1 in 3000. The …

Neurofibromatosis 1 (NF1) is a multisystem disorder characterized by multiple café au lait
macules, intertriginous freckling, multiple cutaneous neurofibromas, and learning disability …

The neurofibromatoses are a group of three heterogeneous disorders that include
neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis. NF1 …

Background There has been recent systematic review of key evidence in psychosocial
intervention in autism but little review of biological treatments. Methods We analyse the …

Abstract Neurofibromatosis 1 (NF1) is an autosomal dominant genetic disorder that presents
with variable phenotypes as a result of mutations in the neurofibromatosis type 1 (NF1) gene …

Aim The last systematic review of research on the behavior of children with
neurofibromatosis type 1 (NF1) was in 2012. Since then, several important findings have …

We present the Anterior Modifiers in the Emergence of Neurodevelopmental Disorders
(AMEND) framework, designed to reframe the field of prospective studies of …

Importance Recent reports have demonstrated a higher incidence of autism spectrum
disorder (ASD) and substantially elevated autistic trait burden in individuals with …